Proof-of-concept phase I trial of CAM-1 for Staphylococcal infections, including methicillin-resistant Staphylococcus aureus

Trial Profile

Proof-of-concept phase I trial of CAM-1 for Staphylococcal infections, including methicillin-resistant Staphylococcus aureus

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs CAM 1 (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections; Staphylococcal infections
  • Focus Adverse reactions
  • Sponsors Galapagos NV
  • Most Recent Events

    • 07 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top